New PET tracer BAY-94-9392 distinguishes tumors from inflammation in vivo; phase I trials ongoing April 12, 2011
Danoprevir/ritonavir shows anti-HCV efficacy in combination with P/R in P/R null reponders April 11, 2011
Arena Pharma describes new potent and selective lysophospholipid S1P1 receptor agonists April 11, 2011
Novel PLK4 inhibitors demonstrate antiproliferative activity in models of breast cancer April 11, 2011
Antitumor activity of TAK-441 involves inhibition of zinc finger protein GLI1 expression April 8, 2011
RSS